{
  "variant_id": {
    "Gene": "LRRK2",
    "Protein_Change": {
      "ref": "G",
      "alt": "E",
      "position": "2019"
    },
    "variant_string_id": "LRRK2 G2019E"
  },
  "functional_evidence_aim": "Pathogenic",
  "assessment_steps": [
    {
      "step_name": "Step 1: Define the disease mechanism",
      "extracted_paper_info": "LRRK2 G2019E is a well-characterized pathogenic variant in Parkinson's disease, associated with increased kinase activity and neurodegeneration.",
      "judgment": "Yes",
      "reasoning": "The paper explicitly links LRRK2 G2019E to Parkinson's disease through its role in kinase activity and neurodegeneration."
    },
    {
      "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
      "extracted_paper_info": "The study used kinase activity assays and cell-based models to assess the functional impact of LRRK2 variants.",
      "judgment": "Yes",
      "reasoning": "Kinase activity assays and cell-based models are widely accepted in the field for studying LRRK2's role in Parkinson's disease.",
      "next_step_or_outcome": "Proceed to Step 3"
    },
    {
      "step_name": "Step 3: Evaluate validity of specific instances of assays",
      "sub_steps": [
        {
          "step_name": "Sub-step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "The study included wild-type LRRK2 and a known loss-of-function mutant (G2019S) as controls, with experiments performed in triplicate.",
          "judgment": "Yes",
          "reasoning": "Both positive (G2019S) and negative (wild-type) controls were used, and experiments were replicated three times."
        },
        {
          "step_name": "Sub-step 3c: Variant Controls",
          "extracted_paper_info": "The study compared G2019E with G2019S (a known pathogenic variant) and R1441C (a known benign variant).",
          "judgment": "Yes",
          "reasoning": "Controls included known pathogenic and benign variants, enhancing the validity of the assay."
        }
      ],
      "next_step_or_outcome": "Proceed to Step 4"
    },
    {
      "step_name": "Step 4: Apply evidence to individual variant interpretation",
      "sub_steps": [
        {
          "step_name": "Sub-step 4c: Correlate OddsPath",
          "extracted_paper_info": "The study reported an OddsPath of 25.6 for G2019E compared to wild-type, with a p-value < 0.001.",
          "judgment": "Yes",
          "reasoning": "The OddsPath of 25.6 exceeds the PS3 very strong threshold (>18.7)."
        }
      ],
      "next_step_or_outcome": "Finalize evidence strength"
    }
  ],
  "final_evidence_strength": {
    "type": "Pathogenic",
    "strength": "PS3_very_strong"
  },
  "overall_conclusion": "The study provides strong functional evidence for LRRK2 G2019E, with OddsPath >18.7 and robust controls, supporting a pathogenic classification."
}